An ATM of 25M would be nice, wouldn't have to worry about funding for a long time.
But this just looks like someone dumping, taking profit near the close.
If there was a block offering, I'd be a buyer. they'd probably block it at 5.50 probably 5.
Someone has to pay Levitt's 525k annual salary. lolol Either way, the safety profile looks good and the drug can be applied to many diseases. I'm a buyer while its still under 10.
They have the platinum preclinicial stuff whose profile looks its similiar to aldoxorubicin in that they take a proven method and improve it, so there is potential. I just wouldn't get carried away with this one stock though.
nice try, market maker just ran the stops to collect or harvest shares, too much demand and institutions want more shares! Did you see all the shares vacuumed up in a heartbeat, look at the volume, this one will likely close modestly down, nowhere near its lows of the day.